Publications by authors named "Isrid Sturm"

Claim this Profile
T
Th-Labeled Anti-CD22 Antibody (BAY 1862864) in Relapsed/Refractory CD22-Positive Non-Hodgkin Lymphoma: A First-in-Human, Phase I Study.
Ola Lindén, Andrew T Bates, David Cunningham, Cecilia Hindorf, Erik Larsson, Isrid Sturm

Cancer Biother Radiopharm· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1b study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors.
Colin Weekes, A Craig Lockhart, James J Lee, Isrid Sturm, Adriaan Cleton

Int J Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancers.
Matthew D Hellmann, Isrid Sturm, Zuzana Jirakova Trnkova, John Lettieri, Konstanze Diefenbach

Clin Lung Cancer· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of dance on cancer-related fatigue and quality of life.
Isrid Sturm, Johanna Baak, Benjamin Storek, Annette Traore, Peter Thuss-Patience

Support Care Cancer· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of patients with multiple myeloma and impaired renal function with lenalidomide: results of 4 German centers.
Katharina Oehrlein, Christian Langer, Isrid Sturm, Wolfram Pönisch, Corinna Hahn-Ast

Clin Lymphoma Myeloma Leuk· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large paraganglioma of the abdominal cavity: a case report and review of the literature.
Annegret Kunitz, Stefan Pahl, Petr Podrabsky, Eva Wardelmann, Isrid Sturm

Onkologie· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial.
Andreas Engert, Andreas Josting, Heinz Haverkamp, Matthias Villalobos, Andreas Lohri, Isrid Sturm

J Clin Oncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombocytopenia as first manifestation of splenic angiosarcoma.
Simon Raffel, Bert Hildebrandt, Christian Grieser, Stefan Pahl, Isrid Sturm

Ann Hematol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
Patricia Grabowski, Jörg Schrader, Julia Wagner, Dieter Hörsch, Rudolf Arnold, Isrid Sturm

Clin Cancer Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
Thacharot Boonyapakorn, Ingrid Schirmer, Peter A Reichart, Isrid Sturm, Gero Massenkeil

Oral Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful long-term monotherapy with rituximab in a patient with chronic lymphocytic leukemia of the B-cell-lineage: a case report.
Isrid Sturm, Joachim Oertel, Stephan Oertel, Jörg Westermann, Antonio Pezzutto

J Med Case Rep· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sickle cell disease, pulmonary hypertension, and sarcoidosis.
Lorenz H Lehmann, Hanno Riess, Isrid Sturm

Ann Hematol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of bortezomib-based chemotherapy and extracorporeal free light chain removal for treating cast nephropathy in multiple myeloma.
Ulrike Bachmann, Ralf Schindler, Markus Storr, Andreas Kahl, Achim Joerres, Isrid Sturm

NDT Plus· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silencing of APAF-1 in B-CLL results in poor prognosis in the case of concomitant p53 mutation.
Isrid Sturm, Andrew G Bosanquet, Silke Radetzki, Michael Hummel, Bernd Dörken

Int J Cancer· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy.
Isrid Sturm, Beate Rau, Peter M Schlag, Peter Wust, Bert Hildebrandt

BMC Cancer· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of neuroendocrine differentiation and the p53/BAX pathway in UICC stage III colorectal carcinoma identifies patients with good prognosis.
Patricia Grabowski, Isrid Sturm, Katharina Schelwies, Kerstin Maaser, Heinz-Johannes Buhr

Int J Colorectal Dis· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis.
Isrid Sturm, Andrew G Bosanquet, Michael Hummel, Bernd Dörken, Peter T Daniel

BMC Cancer· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of multimarker analysis in stage III colorectal cancer: one step forward towards an individualized therapy decision.
Patricia Grabowski, Kerstin Maaser, Christoph Hanski, Harald Stein, Isrid Sturm

Onkologie· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.
Beate Rau, Isrid Sturm, Hermann Lage, Stefan Berger, Ulrike Schneider

J Clin Oncol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis.
Dilek Güner, Isrid Sturm, Philipp Hemmati, Sandra Hermann, Steffen Hauptmann

Int J Cancer· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of p53/BAX in primary colorectal carcinoma: low BAX protein expression is a negative prognostic factor in UICC stage III tumors.
Katharina Schelwies, Isrid Sturm, Patricia Grabowski, Hans Scherübl, Isabell Schindler

Int J Cancer· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines.
Silke Radetzki, Claus-Henning Köhne, Clarissa von Haefen, Bernhard Gillissen, Isrid Sturm

Oncogene· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis